Drug intelligence / Profile preview

decloro dihydroxy difluoro ethycloprostenolamide

Development stage
Unknown
Lead developer
Athena Cosmetics
Modality
Small Molecules
Administration
Topical
01

Overview

Decloro dihydroxy difluoro ethycloprostenolamide is a synthetic small molecule prostaglandin analog, specifically an ethyl amide derivative of tafluprost. It is primarily utilized as an active ingredient in over-the-counter cosmetic eyelash and eyebrow enhancement serums, such as RevitaLash Advanced. The compound acts as an agonist at prostaglandin receptors, which is believed to prolong the anagen (active growth) phase of the hair follicle cycle, leading to increased length and density of lashes. Despite its widespread use in the cosmetic industry, it is not approved as a pharmaceutical drug for this indication. In 2026, the European Scientific Committee on Consumer Safety (SCCS) raised significant safety concerns regarding its potent pharmacological activity and potential for reproductive toxicity, concluding it could not be considered safe for cosmetic use. Side effects are similar to prescription prostaglandin analogs (like bimatoprost) and include iris pigmentation changes, eye irritation, and periorbital fat loss.

Brand names
RevitaLash Advanced
Other names
Dechloro Dihydroxy Difluoro EthylcloprostenolamideTafluprost Ethyl Amide1185851-52-8
02

Targets

PTGFR (Prostaglandin F2 alpha receptor)

Beyond the preview

Go deeper on decloro dihydroxy difluoro ethycloprostenolamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on decloro dihydroxy difluoro ethycloprostenolamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call